A 6-Week, Multicentre, Randomised, Double-Blind, Double-Dummy, Active-Controlled, Clinical Safety Study of Lumiracoxib and Rofecoxib in Osteoarthritis Patients
BMC Musculoskeletal Disorders - United Kingdom
doi 10.1186/1471-2474-9-118
Full Text
Open PDFAbstract
Available in full text
Date
September 8, 2008
Authors
Publisher
Springer Science and Business Media LLC